Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thermostable respiratory synctial virus (RSV) vaccine compositions

Thermostable respiratory synctial virus (RSV) vaccine compositions

US Patent 10369213 · Granted Aug 6, 2019

Estimated economic value: $75,148,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for producing Streptococcus pneumoniae capsular polysaccharide carrier p2025
Subcutaneous administration of anti-CD38 antibodies2025
Formulations of dengue virus vaccine compositions2025
Formulations of dengue virus vaccine compositions2025
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier p2024
Methods for producing Streptococcus pneumoniae capsular polysaccharide carrier p2024
Methods for providing a homogenous solution of lyophilized mutant diptheria toxi2024
Formulations of dengue virus vaccine compositions2024
Methods for treating chronic sinusitis with nasal polyps by administering an IL-2022
Thermally stable rotavirus vaccine formulations and methods of use thereof2020
Thermally stable rotavirus vaccine formulations and methods of use thereof2020
HPV vaccine formulations comprising aluminum adjuvant and methods of producing s2020